Syneron Medical Ltd
(ELOS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | N/A | -7,290 | N/A |
| Depreciation Amortization | N/A | N/A | N/A | 7,930 | N/A |
| Other Working Capital | N/A | N/A | N/A | -23,660 | N/A |
| Other Operating Activity | 0 | 0 | 0 | 3,230 | 0 |
| Operating Cash Flow | $N/A | $N/A | $N/A | $-19,790 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -1,120 | N/A |
| Net Acquisitions | N/A | N/A | N/A | -15,050 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 26,100 | 0 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $9,930 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | 0 | -6,910 | 0 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $-6,910 | $N/A |
| Exchange Rate Effect | N/A | N/A | N/A | -90 | N/A |
| Beginning Cash Position | N/A | N/A | N/A | 62,310 | N/A |
| End Cash Position | N/A | N/A | N/A | 45,460 | N/A |
| Net Cash Flow | $N/A | $N/A | $N/A | $-16,850 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | N/A | N/A | -19,790 | N/A |
| Free Cash Flow | 0 | 0 | 0 | -19,790 | 0 |